Business
Dr. Nalinda Jayatissa visits LAUGFS Life Sciences’ State-of-the-Art (LVP) pharmaceutical facility
The Minister of Health and Mass Media, Dr. Nalinda Jayatissa, undertook an observational visit to the state-of-the-art sterile pharmaceutical manufacturing facility of LAUGFS Life Sciences (Pvt) Ltd, located within the BOI Export Processing Zone, Koggala. This visit reflects the company’s commitment to strengthening Sri Lanka’s healthcare system through world-class local manufacturing. Marking a significant milestone for the country’s healthcare industry, LAUGFS Life Sciences is advancing sterile infusion therapy production, reducing reliance on imports, delivering economic and clinical benefits, and positioning Sri Lanka as a regional hub for quality-driven pharmaceutical manufacturing through innovation, regulatory compliance, and private-sector investment.
The Minister was warmly welcomed by Dr. Ravi Edirisinghe, Group Chief Executive Officer of LAUGFS Holdings Limited, Dr. Rajiv Perera, Chief Executive Officer of LAUGFS Life Sciences (Pvt) Ltd., Vipin Kumar Head of Quality, Ranjith Reddy, General Manager – Operations, and Wasaam Ismail, General Manager – Head of Corporate Communications, along with senior managers, quality specialists, and engineers of the facility.
During the visit, the Minister observed LAUGFS Life Sciences’ advanced sterile infusion production lines. The company is preparing to introduce Large Volume Parenterals (LVPs) using Euro Multiport systems and Form-Fill-Seal (FFS) technology. Euro Multiport ensures high-safety, multi-access containers for clinical use, while FFS automates forming, filling, and sealing in a sterile environment, minimising human intervention and contamination risks. These innovations aim to transform infusion therapy in Sri Lanka by reducing import dependence, ensuring steady supply, and offering affordable solutions for both public and private healthcare sectors.
Commending the initiative, the Minister of Health and Mass Media, Dr. Nalinda Jayatissa, stated, “This project is a commendable step forward for Sri Lanka’s healthcare sector. By investing in advanced pharmaceutical manufacturing, LAUGFS Life Sciences directly supports the Government’s vision of enhancing local production, saving valuable foreign exchange, and providing our citizens with reliable, world-class medical solutions. Public-private partnerships of this nature are critical to building a resilient healthcare system and ensuring patient safety and continuity of treatment.”
Commenting on this significant occasion, Dr. Ravi Edirisinghe, Group Chief Executive Officer of LAUGFS Holdings Limited, remarked, “At LAUGFS, we believe in creating industries that bring long-term value to Sri Lanka. Through LAUGFS Life Sciences, we are making strategic investments in sterile pharmaceutical technologies that will not only benefit the local healthcare sector but also strengthen our position as a regional hub for pharmaceutical manufacturing.”
Adding his perspective, Dr. Rajiv Perera, Chief Executive Officer of LAUGFS Life Sciences, commented, “We are committed to ensuring that Sri Lanka has access to globally benchmarked infusion therapies through our advanced LVP production lines. With the integration of Euro Multiport and Form-Fill-Seal technologies, we are setting new standards in quality, safety, and efficiency that will directly benefit both patients and healthcare providers.”
LAUGFS Life Sciences specialises in manufacturing Large Volume Parenteral (LVP) IV solutions to meet critical healthcare needs across local and regional markets. Operating a state-of-the-art facility at the BOI Export Processing Zone, Koggala, it utilises advanced production technologies and adheres to cGMP guidelines set by WHO, NMRA, and other global regulatory authorities to ensure stringent quality assurance. With a portfolio of 20+ IV fluid products, including electrolytes, dextrose solutions, and critical care medications, LAUGFS Life Sciences manufactures in high-quality Non-PVC polypropylene (PP) bags using Form Fill-Seal (FFS) & Eurocap technology, supported by a fully automated production process that guarantees maximum efficiency, product integrity, and consistency.
Business
APHNH aims to make Sri Lanka more competitive for healthcare investment
Sri Lanka private healthcare leaders recently pledged an action plan with timelines to address the practical priorities of Sri Lanka’s healthcare sector while making it more viable for local and foreign investments.
The Association of Private Hospitals and Nursing Homes (APHNH) has committed to converting recommendations from its first Healthcare Leadership Summit into a trackable outcome document with defined actions, responsibilities, and timelines, marking a shift from discussion to implementation in sector reform efforts.
The summit held on March 9 at Waters Edge, Colombo, brought together hospital leaders, policymakers, regulators, insurers, and international experts to address practical priorities for Sri Lanka’s healthcare sector.
A key outcome of the summit was APHNH’s plan to consolidate recommendations into a single, trackable charter that will outline specific actions, assign responsibilities, establish timelines, and provide periodic progress updates.
“Our objective is to bring the right decision-makers into one room and focus on what can be implemented, not only what can be discussed, ” said Raveen Wickremesinghe, President of APHNH. “We are committed to taking the inputs from today and converting them into a clear, trackable set of actions that strengthens quality, transparency and public confidence, while supporting national health priorities. “
The summit featured insights from Dr. Hafeez Rahman Padiyath, Dr. Hamdani Anver, and Chandana L. Aluthgama on scaling quality and operational discipline. A keynote and fireside discussion with Dr. Paiboon Eksangsri, President of the Private Hospital Association of Thailand, explored lessons from Thailand’s private healthcare development and conditions for making Sri Lanka more competitive for healthcare investment.
By Sanath Nanayakkare
Business
Atlas SipSavi Naththal Poronduwa records positive public participation, benefiting 10,000 students
Atlas, Sri Lanka’s No. 1 learning brand, successfully concluded Atlas SipSavi Naththal Poronduwa, a national initiative that saw strong public participation in supporting children at risk of dropping out of school due to financial hardship. At a time when more than 22,000 Sri Lankan children leave school each year due to rising economic challenges, the initiative reinforced Atlas Sipsavi’s long-standing ‘No Child Left Behind’ promise by turning seasonal generosity into meaningful educational support.
The initiative reached 10,000 students, with beneficiary schools carefully selected to ensure support reached those most in need. The collected books were distributed to children at risk of dropping out, including those whose education had been disrupted by recent adverse weather, ensuring students had essential learning resources at the start of the new school term. Through its flagship Atlas SipSavi programme, the brand focused on improving access to education by providing essential learning tools, scholarships, and infrastructure to create better learning environments, bringing its purpose of ‘making learning fun’ to life in a meaningful way. As part of the initiative, the public was invited to donate schoolbooks, with each contribution matched one-for-one by Atlas. Donation boxes were placed at all Keells outlets island-wide and at Sarvodaya District Offices, making it easy for communities to take part.
Business
John Keells Logistics expands strategic engagement with CWIT through inter-terminal transport operations
John Keells Logistics (Pvt) Ltd (JKLL), one of Sri Lanka’s leading third-party logistics solutions providers, has successfully expanded its operational engagement with Colombo West International Terminal (Private) Limited (CWIT), through inter-terminal transport services within the Port of Colombo. This enhanced engagement further strengthens CWIT’s efforts to improve operational efficiency, reliability, and scalability across terminal activities.
Inter-terminal transport plays a critical role in modern port operations, requiring high levels of coordination, precision, and operational discipline. JKLL’s appointment for ITT operations reflects CWIT’s confidence in the company’s demonstrated capabilities in managing complex transport operations within a high-throughput port environment.
The ITT operations are underpinned by JKLL’s technology-enabled logistics framework, incorporating real-time fleet tracking, performance monitoring systems, and data-driven operational planning. These capabilities provide enhanced visibility and control over transport movements, while ensuring compliance with established safety, productivity, and service quality standards.
The awarding of this engagement to JKLL is a testament to the successful implementation of the Inter-Terminal Vehicle (ITV) operations undertaken by John Keells Logistics at CWIT during the previous year. The ITV assignment was executed through structured operating procedures and disciplined service delivery, contributing to improved cargo movement, operational coordination, and service continuity within the terminal. The performance outcomes of the ITV operations provided the basis for the subsequent expansion of the partnership into ITT services.
-
News6 days agoRepatriation of Iranian naval personnel Sri Lanka’s call: Washington
-
Features6 days agoWinds of Change:Geopolitics at the crossroads of South and Southeast Asia
-
News5 days agoProf. Dunusinghe warns Lanka at serious risk due to ME war
-
Sports4 days agoRoyal start favourites in historic Battle of the Blues
-
Sports3 days agoThe 147th Royal–Thomian and 175 Years of the School by the Sea
-
News3 days agoHistoric address by BASL President at the Supreme Court of India
-
Business7 days agoSeven decades of sartorial excellence: The legacy of Linton Master Tailors in Kandy
-
News4 days agoCEBEU warns of operational disruptions amid uncertainty over CEB restructuring
